Viewing nowGlitarzone Tablet 15 mg (Pioglitazone Hydrochloride)
Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Il Dong Pharmaceutical Co., Ltd.

MFDS item code 200710496 · Approved 2007.09.14 · Insurance code 642900010
Improvement and treatment of blood sugar control in type 2 diabetes
This medication helps improve blood sugar control in patients with type 2 diabetes by assisting dietary and exercise therapy. It can be used alone, and if there is no improvement in blood sugar despite the use of other oral hypoglycemic agents, it can be combined with sulfonylureas, metformin, or insulin. Additionally, it is important to accompany this medication with nutritional counseling and, in some cases, weight loss and exercise therapy. Such comprehensive treatment effort is needed for both initial therapy and to maintain the ongoing effectiveness of the medication. Therefore, this medication effectively improves blood sugar control in patients with type 2 diabetes.
This medication is taken orally once daily, regardless of meals. It is started at a dose of 15 mg once daily as monotherapy, and if the effect is insufficient, the dose may be increased to 30 mg once daily. For combination therapy, it is administered at a dose of 15 mg once daily with sulfonylureas, metformin, and insulin. The maximum recommended dose should not exceed 30 mg once daily.
There is no experience in children under 18 years; therefore, its use is not recommended.
This medication is used to treat type 2 diabetes and only shows effectiveness in lowering blood sugar with the assistance of insulin. This medication may put some patients at risk of worsening or newly developing congestive heart failure, so it should not be used in patients with heart failure or a history of heart failure. After starting treatment or increasing the dose, it is crucial to closely monitor for sudden weight gain or symptoms of heart failure, such as shortness of breath, and consult a doctor immediately if symptoms arise. Additionally, this medication can cause fluid retention, leading to edema, so patients with edema or a high risk of heart disease should use it cautiously. Patients with active bladder cancer or a history of bladder cancer should not use this medication, and they should inform their doctor immediately if they experience hematuria or urinary disorders during treatment. Patients with impaired liver function should also exercise caution and have regular liver function tests before and during treatment. The risk of hypoglycemia may increase when this medication is used in combination with other diabetes medications, so dosage adjustments of the concomitant medications may be necessary. Premenopausal women should be aware that this medication may induce ovulation and increase the possibility of pregnancy; thus, appropriate contraceptive measures are recommended. Elderly patients or those with reduced kidney function should also be cautious, and regular monitoring of weight gain, edema, and symptoms of heart failure should be conducted during the use of this medication. In cases of overdose, no specific symptoms may be observed; however, if unusual symptoms occur, immediate medical attention is required. This medication is taken once daily, and in case a dose is missed, care should be taken not to double the next day's dose. Finally, keep it out of reach of children and store it in its original container to maintain quality.
Congestive heart failure, signs and symptoms of heart failure (including excessive and rapid weight changes, shortness of breath, edema), severe edema, severe allergic reactions (such as hives, severe swelling, chest tightness, difficulty breathing, cold sweat, paleness), severe dermatologic reactions (including severe rashes with fever, blisters, skin peeling, oral/ocular mucosal pain), respiratory issues (shortness of breath or difficulty breathing, asthma attacks, cough with fever).
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a container that prevents light and air from entering, and it should be kept away from humid areas. The storage temperature should be between 15 to 30 degrees, with a preference for around 25 degrees.
White round tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Il Dong Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 33.06mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Hanol Bio Pharma Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Kujoo Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Kyungdong Pharm Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.